Structural alterations occur in the long arm of chromosome 3 in approximately 2% of patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). The major alterations are inv(3)(q21q26) and t(3;3)(q21;q26) and are often classified as the 3q21q26 syndrome. We previously reported that the EVll gene is transcriptionally activated in AMLs with t(3;3)(q21;q26) and inv(3)(qZlq26) and that the chromosomal breakpoints at 3q26 in the translocations were 5' of the EVll gene, whereas the breakpoints in the inversion cases were 3' of the gene. In these studies, four additional cases of AML with inv(3)(q21q26) are shown to express the TRUCTURAL ABNORMALITIES in the long arm of chromosome 3 have been detected in approximately 2% of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) cases. Major abnormalities include paracentric inversions, homologous translocations, and insertions or duplications of chromosome 3 involving bands 3q21 to q26. In particular, inv(3)(q21q26) and t(3;3)(q21;q26) have been the most frequently observed rearrangements in this group.'-3 This group of AMLs, termed the 3q21q26 syndrome, shows specific clinical features, including normal or elevated platelet counts, hyperplasia with dysplasia of megakaryocytes, poor response to chemotherapy, and poor prognosis.',' Recently, we and others have found that the EVll gene, which maps to 3q26, is activated in AMLs with various chromosome 3q26 abnormalities including t(3;3) (q21;q26), t(2;3)(q21;q27), ins(3)(q21q25q27), de1(3)(q27), inv(3)(q21q26), t(3;21)(q26;q22), and t(3;5)(qter3q29:: 3ql1.2+3q29::5pl 1-5qter).6K
TRUCTURAL ABNORMALITIES in the long arm of chromosome 3 have been detected in approximately 2% of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) cases. Major abnormalities include paracentric inversions, homologous translocations, and insertions or duplications of chromosome 3 involving bands 3q21 to q26. In particular, inv(3)(q21q26) and t(3;3)(q21;q26) have been the most frequently observed rearrangements in this group.'-3 This group of AMLs, termed the 3q21q26 syndrome, shows specific clinical features, including normal or elevated platelet counts, hyperplasia with dysplasia of megakaryocytes, poor response to chemotherapy, and poor prognosis.',' Recently, we and others have found that the EVll gene, which maps to 3q26, is activated in AMLs with various chromosome 3q26 abnormalities including t(3;3) (q21;q26), t(2;3)(q21;q27), ins(3)(q21q25q27), de1(3)(q27), inv(3)(q21q26), t(3;21)(q26;q22), and t(3;5)(qter3q29:: 3ql1.2+3q29::5pl 1-5qter).6K
The Evi-l (Ecotropic Virus integration site-l) gene was identified as the gene associated with a common site of retroviral integration in murine myeloid leukemias.' Retroviral insertions occur either between the noncoding exon 1 and exon 2 in a region termed the Evi-I locus or approximately 90 kb 5' of the Evi-l gene in a region termed thejim-3 (friend integrations in myeloblastic leukemias-3) locus.lo," The Evi-I gene encodes a zinc finger DNA binding protein that contains two domains of zinc fingers. The first, aminoterminal domain of seven zinc fingers binds the sequence GA(T/C)AAGA(T/C)AAGATAA,"" whereas the second carboxyl domain of three fingers binds the sequence GAA-GATGAG.14 The Evi-l gene is not normally expressed in hematopoietic cells but rather is limited to expression in the kidney and ovary.'' During development, Evi-I gene expression is detected in a number of sites, including the embryonic kidney, the foot pad, and Mullerian duct, suggesting that the gene product is involved in organogenesis during development."
In AMLs, the ectopic expression of the Evi-l gene in hematopoietic cells is associated with transformation. The mechanisms of transformation are not defined; however, it is hypothesized that the inappropriate expression of the Evil gene interferes with normal differentiation. In particular, inappropriate expression of the Evi-l gene in cell lines can 0 1994 by The American Society of Hematology.
block granulocyte colony-stimulating factor (G-CSF)-induced terminal differentiation of granulocytes" as well as erythropoietin (Epo)-induced erythroid differentiation.I8 In the latter case, it was shown that Evi-I can block the transcriptional activity of GATA-1, a factor that is required for normal erythroid differentiation," by competing with GATA-1 for binding to GATA containing promoter elements.
We have previously mapped the chromosomal breakpoints of t(3;3)(q21;q26) cases within approximately 330 kb upstream of the EVll gene by pulsed-field gel electrophoresis (PFGE) analy~is.~ More recently, we have shown that six cases of inv(3)(q21q26) contain rearrangements that are downstream of the coding region of the EVll gene.' In the present study, we analyzed four additional cases of AML with inv(3)(q21q26) and show that they express the EVll gene and contain breakpoints downstream of the EVll gene. The 3q21 breakpoint regions for these cases, and other cases with t(3;3) and inv(3), were mapped and found to cluster in Case no. 2. A 3 1 -year-old man was admitted because of general fatigue and gingival bleeding. His peripheral WBC count was 4.1 X IO'L with 95% blasts and the platelet count was 350 X IO'L. Bone marrow aspirates were dry-tap, but the blast cells in the peripheral blood showed negative specific staining for peroxidase, terminal deoxytransferase, or platelet peroxidase. Blast cell surface markers were CD34', CD33-, CD13 , CDw41-, and CD42-, with neither T-or B-cell markers. The diagnosis of AML (FAB-MO) was made. The karyotype of the blast cells was 46, XY, inv(3)(q21q26). The patient received multiple chemotherapeutic regimens without obtaining complete remission. During the chemotherapy, the blast cells changed to biphasic type, with myeloid and lymphoid surface markers. The patient died of pneumonia during reinduction therapy 1 year after diagnosis.
Cuse no. 3 . A 64-year-old woman was referred to University Hospital with putative diagnosis of leukemia. The peripheral cell counts were WBC at 9.8 X IO"/L, with 83% of blasts, and platelets at 310 X IO'/L. Staining for platelet peroxidase (PPO) was positive and therefore she was diagnosed as AML (FAB"7).
The karyotype of the blast cells was 45, XX, inv(3)(q21q26), -7. She was treated with standard chemotherapeutic protocols without achieving remission, and died of pneumonia within 1 year after diagnosis.
C u e no. 4. A 4-year-old boy was diagnosed with the myelodysplastic syndrome secondary to chemotherapy for neuroblastoma at 6 months of age. After treatment with a low dose of AraC, his disease proceeded to overt leukemia. Karyotype analysis showed that the leukemia cells were 45, XY, inv(3)(q21q26), -7. He died after 3 years due to the progression of the disease.
Leukemia Cells and Cell Lines
After obtaining patient consent, bone marrow cells and peripheral blood cells were aspirated and an equal volume of phosphate-buffered saline (PBS) was added. Mononuclear cells (MNCs) were separated by centrifugation with the Ficoll-opaque cushion (Pharmacia, Uppsala, Sweden). After washing the cells with PBS once, MNCs were resuspended into RPM1 1640 with 10% dimethyl sulfoxide (DMS0)/20% fetal calf serum and stored in liquid nitrogen until use. Establishment of the somatic cell hybrid line HlOC from AML with t(3;3)(q21;q26) and the UCSD/AML cell line have been deand was a patient with AML FAB-M4 that evolved from chronic myelogenous leukemia (CML). 
Southern and Northern Blot Analyses
High molecular weight DNA was extracted from MNCs and cell lines by proteinase K digestion and phenol/chloroform extraction.
Seven micrograms of DNA was digested with appropriate restriction enzymes, subjected to electrophoresis on 0.8% or 1 .O % agarose gel, transferred to charged nylon filters (Pall BioSupport, East Hills, NY), and hybridized to DNA probes labeled by the random hexamer method." Total cellular RNA was extracted by acid guanidine isothiocyanate-phenol-chloroform e x t r a c t i~n .~~ Ten micrograms of RNA was electrophoresed and transferred onto nylon filters. Blots were hybridized to "P-labeled probes under the conditions published previously.' The probe for the ribophorin I gene was a 2-kb cDNA clone (pBQ21) obtained by screening a cDNA library from UCSD/ AMLl cells with genomic fragments from 3q21. The identity of the cDNA clone was established by sequencing. The probe for the EVll transcripts was a human cDNA clone as previously described.'
Isolation ($Phage and Cosmid Clones
Approximately 5 X IOr recombinant phages of EMBL3 human genomic DNA library from normal peripheral blood cells were screened with the "P-labeled probe according to the standard procedures." A human placental DNA cosmid library was purchased from Stratagene (La Jolla, CA) and was screened by standard procedures.
PFGE
Agarose plugs from patient cells or from cultured cells were prepared by adding 1% low melting point agarose in PBS to an equal volume of cell suspension in PBS (1.2 to 2.4 X IO' cells/mL). The plugs were incubated in 0.5 mol/L EDTA/I% N-laurylsarcosineh mg of proteinase WmL for 2 nights at SOT, and washed twice at room temperature for 2 hours in I O m m o l n Tris-HCI, pH 7 3 1 mmol/L EDTA/I mmol/L phenylmethylsulfonyl fluoride. DNAs in the plugs were digested with the indicated enzymes overnight. After digestion, the plugs were loaded onto a 1 % agarose gel. PFGE was performed on a CHEF Mapper apparatus (Bio-Rad, Richmond, CA) at 14°C with ramped pulses from 26.3 to I15 seconds for more than 25 hours at a constant voltage of 200 V. After the DNAs were transferred onto nylon membranes, the filters were hybridized as described previously.""
Construction and Screening of cDNA Libraty
cDNA libraries were constructed with poly(A) selected mRNA from UCSD/AML-I cells by published procedures." In brief, oligo(dT)-primed synthesized cDNAs were ligated with EcoRI adaptors, and cloned into EcoRI-digested AgtlO cloning vector (Promega, Madison, Wl). After packaging cDNA with commercial packaging kits (Stratagene), phage plaques ( I X IO') were screened with the probes labeled by the random primer synthesis kit (Stratagene).
Nucleotide Sequencing
Nucleotide sequences of cDNA clones were determined by polymerase chain reaction (PCR) cycling DNA sequence method with f m d DNA Sequencing System (Promega), based on the dideoxynucleotide chain termination reaction." 
RESULTS

Clinical Characteristics of Four Cases of AMLs With inv(3)
The characteristics of the four new cases of AML examined in this study are detailed in the case reports. Leukemic cells from all four patients had the phenotype of myeloid cells, although representing different stages of differentiation. Two of the four cases contained monosomy 7 in addition to inv(3)(q21q26). Cases no. 1 and 4 were initially diagnosed with MDS and converted to leukemias within 1 year. In case no. 4, the inv(3) karotype was present at diagnosis of MDS but the status of case no. 1 at diagnosis is not known. All the cases responded poorly to chemotherapy and failed to achieve remission. Elevated platelets, often associated with the 3q21q26 syndrome, were seen in cases no. 2 and 3. The leukemic blasts from cases no. 1 and 2 responded to granulocyte-macrophage-CSF (GM-CSF) in tissue culture and grew well for a few months in GM-CSF, but eventually died out.
Detection of EVII Transcripts in AMLs With inv(3)
To assess EVII gene expression, total RNA from leukemic blasts was used for Northern blot hybridization. As shown in Fig 1, all four cases expressed a major 6.0-kb transcript that is comparable in size to the normal EVIl transcript detected in ovary or kidneys:' indicating that the EVII gene itself was not disrupted. Consistent with this finding, Southem hybridization with a 3.6-kb EVII cDNA probe, covering the region from exon 1 to the end of the coding region, failed to detect rearrangements (data not shown).
Detection of Breakpoints Downstream of the EVII Gene
To detect breakpoints outside of the EVIl gene, PFGE was used. In previous studies, we constructed a restriction map of approximately 1,700 kb surrounding the EVIl gene and mapped t(3;3)(q21q26) breakpoints to 15 kb and approximately 300 kb upstream of the EVII gene," as indicated in Fig 2. The position of the glucose transporter (GLUT2) gene, which had been previously localized to 3q,".'" was determined to be approximately 500 kb 5' of the EVII gene by PFGE (E.P. and J.N, unpublished data). Also shown are the positions of the EAP and MDSI genes. These genes, as well as the EVII, are found in chimeric transcripts with the AMLl gene in cases of AML with t(3;21)(q26;q22)A8 To localize the breakpoints in the inv(3) cases, two probes were used in PFGE. The H1-l cDNA probe detects sequences 3' of a CpG island in the 5' region of the EVII gene, whereas the P1 probe is 5' of the CpG island and is derived from the murine jim-3 equivalent region. The H1-l probe detected rearranged fragments in three of four cases with either Sjil or BssHII digestion (Fig 3) . The sizes of the rearranged Sjil and BssHII fragments ranged from 350 to 450 kb and 250 to 300 kb, respectively. As noted above, no rearrangements were detected by Southern blot hybridization with cDNA probes; therefore, the results suggest that the breakpoints occur 3' of the EVll gene, outside of the coding region. These results are consistent with our previous mapping of 6 inv(3) cases to a region 3' of the EVII gene.' No rearrangements were detected in case no. 4 and thus the breakpoint may lie either 600 kb 5' or 900 kb 3' of the EVIl gene. Lastly, the position of the breakpoint in case 6 had been previously localized7 and is indicated for comparison.
IdentiJication of a Breakpoint Cluster Region at 3q21
Our previous studies did not examine the breakpoint region on 3q2 1. We therefore used probes from a phage containing the breakpoint of a t(3;3)(q21;q26) case (AMLl) to obtain phage and cosmid clones of the 3q21 region. These were used for chromosomal walking to obtain the contigs of cosmids and phages and the restriction map shown in Initially, we sought to map the 3q21 breakpoint for a t(3;3)(q21 ;q26) case, HIOC. Using a probe from the 27A phage (P3), rearrangements were detected that indicated a breakpoint in a 0.7-kb EcoRIIBarnHI fragment. This fragment was used to obtain genomic clones containing the breakpoint that were sequenced and the breakpoint site was identified. Similarly, a Sal VSac I fragment from phage 27A detected a rearrangement in the inv(3) case no. 6 and was used to obtain clones containing the breakpoint and the breakpoint site identified by sequencing.
Analysis of the sequences of the three cases indicated that two of the three involved recombination of Alu repetitive sequences on 3q21 with non-Alu sequences on 3q26. As indicated in Fig S, both t(3;3) breakpoints on 3q21 occurred within an Alu element at the highly conserved TGTAATCC-CAGCA position between box A and box B of the bipartite RNA polymerase I11 promoter.2''.3" The inv(3) breakpoint in case no. 6 did not involve repetitive sequences at either 3q21 or 3q26.
In cases no. 1 and 3, the P3 probe mapped the rearrangements within a S-kb Sac IIEcaRI region covered by the 27A clone by Southern blotting (Fig 6) . Similarly, the P4 probe was used in Southern blotting to localize the A B breakpoint region in case no. 4 to a 2-kb BamHYSac I fragment. The rearrangement in case no. 2 was detected by Southern blotting with the P2 probe that localized the breakpoint to a 10-kb EcoRVBamHI fragment. Thus, the breakpoints in these six cases could be localized to a region of approximately 50 kb at 3q2 1.
Localization of the Ribophorin I Gene in the 3g21
Breakpoint Region
To determine whether the breakpoint region at 3q21 might contain a gene, a variety of subcloned fragments were seBox A quenced andor used to identify evolutionarily conserved sequences by interspecies hybridization. Using the latter approach, a 4-kb EcoRI fragment from the 5' end of the C4 clone was found to hybridize to dog, mouse, and chicken DNA, suggesting that it might contain a highly conserved gene. In Northern blot hybridization, this fragment detected a 2.4-kb mRNA transcript that was expressed in all cell lines examined. To isolate a corresponding cDNA, the probe was used to screen a library from the UCSD/AMLl cell line and a 2-kb cDNA clone, pBQ21, was obtained. Searching of Genbank sequences with the sequences from the end of the 
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" -" -clone identified the cDNA clone as having been derived from the human Ribophorin I gene.3o In Northern blot analysis of various AML cell lines and the AML blasts from the four inv(3) cases, the pBQ21 clone detected a 2.4-kb transcript (Fig 1) . Sequencing of genomic fragments of the region confirmed the presence of the Ribophorin I gene. As indicated in Fig  4, sequences corresponding to the sixth and eighth exons of the rat gene3' were localized by partial sequencing of the region. This allowed the establishment of the orientation of the Ribophorin I gene as being transcribed in the direction of the breakpoints and towards the centromere.
DISCUSSION
Chromosomal rearrangements surrounding the EVIl gene have been found in a variety of cases of MDS and AML with rearrangements of 3q26.4-8 In some of theqe cases, sufficient material has been available to also show the ectopic expression of the EVII gene. In the studies presented here, we examined four additional cases with inv(3)(q21q26) and showed that, in each case, expression of the EVII gene was readily detectable and the major transcript was comparable in size to the normal EVIl transcript. These results support the hypothesis that transformation is a consequence of the inappropriate expression of the normal EVIl gene product. However, in cases containing t(3;21)(q26;q22), the rearrangements produce fusion proteins andlor transcripts involving the AMLI, EAP, or MDSl genes, as well as the normal EVIl gene product. Whether, in these cases, the gene fusion products are uniquely required for transformation by EVII is not known. However, it is possible that they are irrelevant products of rearrangements that are primarily required to activate EVIl gene expression.
In previous studies: DNA rearrangements 3' of the EVIl gene were detected by pulsed-field mapping or in situ hybridization analysis in six cases of AML with inv(3)(q21q26). These rearrangements did not involve the coding region of the gene and were detected over at least 400 kb distal to the gene. With three of the four additional inv(3) cases we have analyzed rearrangements occurring over a comparable region 3' of the gene. The rearrangement in case no. 4 was not detectable by PFGE and therefore could be either 600 kb 5' or 900 kb 3' of the gene. The inv(3) cases that have been mapped are quite distinct from either the t(3;3) or t(3;21) cases in which the rearrangements all have been shown to occur 5' of the gene over a large region. The basis for the orientation differences between the t(3;3) and inv(3) cases does not appear to involve the region on 3q21, as discussed below, suggesting at least two possibilities. One possibility is that the rearrangements must bring an "element" at 3q21 into the region of the EVIl gene and that the region proximal to this element is a highly preferred site of recombination. The other possibility is that there is an orientation specificity for the element at 3q21 such that chromosomal rearrangements distal to the element are not effective. As discussed below, the element may be the Ribophorin I gene and the orientation specificity may be its transcriptional orientation.
Our results further emphasize the considerable distances over which chromosomal rearrangements occur that cause the inappropriate expression of the EVIl gene. In this regard, activation of the EVII gene may represent a paradigm for long-range activation of gene expression in transformation along with the c-myc gene,2,24,32 the bcl-2 gene,"3 and the PRADllbcl-llcyclin D1 gene. 34.35 In the case of the c-myc gene, translocation breakpoints on chromosome 8 are dispersed over distances of at least 300 kb 5' and 3' of the gene and are postulated to perturb the regulation of c-myc expression.'6 In the case of t(8;14) translocations, it was shown by transfection experiments that the Ig heavy chain intron enhancer was sufficient to activate c-myc." More recently, the regulatory elements of the Ig K locus have been identified that are potentially responsible for c-myc activation.3x
In contrast to the chromosomal rearrangements at 3q26, the rearrangements at the 3q21 region were relatively more clustered and, among the cases examined in this study, the rearrangements occurred within a region of about 50 kb. In addition to the cases presented here, we have mapped an additional five cases of inv(3)(q21q26) by PFGE or in situ hybridization with cosmid clones from 3q21. In each case, the breakpoint occurred within the regions spanned by cos- . Therefore, the breakpoint region may cover a larger region at 3q21 than SO kb. Two of the three breakpoints that have been sequenced involve the recombination of an Alu element on 3q21 with non-Alu sequences at 3q26. By hybridization, the 3q21 region containing the breakpoints contains a number of Alu elements, some of which have been localized from limited sequence analysis and are shown in Fig S . Alu elements have been shown to be involved in a number of gene rearrangements associated with both transformation and genetic disorders.3y" It is also of note that the rearrangements normally involve the region between the A and B boxes of the putative RNA polymerase 111 promoter in the left arm." In both of the cases found in our study, this region was also used.
All the rerrangements that could be mapped at 3q21 were located transcriptionally downstream and centromeric of the Ribophorin I gene. The Ribophorin I and I1 genes encode highly conserved transmembrane glycoproteins that are located exclusively in membranes of the rough endoplasmic reticulum. They bind ribosomes and are speculated to be involved in signal recognition complexes that control translocation of secetory and membrane proteins across the microsomal membrane. The Ribophorin I gene is ubiquitously expressed at high levels. As a consequence of the rearrangements, the Ribophorin I gene is placed transcriptionally oriented towards the 3' end of the EVIl gene in inv(3) cases and transcriptionally towards the S' end of the EVII gene in t(3;3) cases (Fig 7) . The orientations would suggest that an enhancer may be located S' of the Ribophorin I gene that is capable of transcriptionally activating the EVII gene over considerable distances. Experiments are currently in progress to explore this possibility.
In summary, the results support the hypothesis that activation of the expression of the EVII gene plays a role in the pathogenesis of the 3q21q26 syndrome. Activation of expression can occur as a consequence of rearrangements over a large distance both S' and 3' of the gene and may result from the positioning of an enhancer element associated with the Ribophorin I gene upstream or downstream of the EVIl gene. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
